<bill session="115" type="h" number="1660" updated="2019-07-15T21:58:07Z">
  <state datetime="2019-01-03">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2019-01-03"/>
  </status>
  <introduced datetime="2017-03-21"/>
  <titles>
    <title type="official" as="introduced">To direct the Administrator of the United States Agency for International Development to submit to Congress a report on the development and use of global health innovations in the programs, projects, and activities of the Agency.</title>
    <title type="short" as="enacted">Global Health Innovation Act of 2017</title>
    <title type="short" as="passed house">Global Health Innovation Act of 2017</title>
    <title type="short" as="passed house">Global Health Innovation Act of 2017</title>
    <title type="short" as="reported to senate">Global Health Innovation Act of 2017</title>
    <title type="short" as="reported to senate">Global Health Innovation Act of 2017</title>
    <title type="short" as="introduced">Global Health Innovation Act of 2017</title>
    <title type="short" as="introduced">Global Health Innovation Act of 2017</title>
    <title type="display">Global Health Innovation Act of 2017</title>
  </titles>
  <sponsor bioguide_id="S001165"/>
  <cosponsors>
    <cosponsor bioguide_id="B001281" joined="2017-05-02"/>
    <cosponsor bioguide_id="C001084" joined="2017-03-21"/>
    <cosponsor bioguide_id="C001078" joined="2017-03-21"/>
    <cosponsor bioguide_id="C001106" joined="2017-08-04"/>
    <cosponsor bioguide_id="C001107" joined="2017-09-28"/>
    <cosponsor bioguide_id="D000617" joined="2017-04-20"/>
    <cosponsor bioguide_id="D000600" joined="2017-03-21"/>
    <cosponsor bioguide_id="D000625" joined="2017-03-21"/>
    <cosponsor bioguide_id="E000179" joined="2017-03-21"/>
    <cosponsor bioguide_id="F000464" joined="2018-01-16"/>
    <cosponsor bioguide_id="K000375" joined="2017-03-21"/>
    <cosponsor bioguide_id="L000582" joined="2017-09-18"/>
    <cosponsor bioguide_id="L000397" joined="2017-07-19"/>
    <cosponsor bioguide_id="R000578" joined="2017-08-25"/>
    <cosponsor bioguide_id="R000435" joined="2017-03-21"/>
    <cosponsor bioguide_id="S000344" joined="2017-03-21"/>
    <cosponsor bioguide_id="S000522" joined="2017-03-21"/>
    <cosponsor bioguide_id="V000081" joined="2017-07-19"/>
    <cosponsor bioguide_id="W000799" joined="2018-01-16"/>
  </cosponsors>
  <actions>
    <action datetime="2017-03-21">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-03-21" state="REFERRED">
      <text>Referred to the House Committee on Foreign Affairs.</text>
    </action>
    <calendar datetime="2017-09-28" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </calendar>
    <action datetime="2017-09-28">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2018-01-17T14:36:47-05:00">
      <text>Mr. Royce (CA) moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2018-01-17T14:36:55-05:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H439-440" label="consideration"/>
    </action>
    <action datetime="2018-01-17T14:36:56-05:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 1660.</text>
    </action>
    <action datetime="2018-01-17T14:45:31-05:00">
      <text>At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.</text>
    </action>
    <action datetime="2018-01-18T19:37:46-05:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H538-539" label="consideration"/>
    </action>
    <vote how="roll" type="vote" roll="34" datetime="2018-01-18T19:44:31-05:00" where="h" result="pass" suspension="1" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34).</text>
      <reference ref="CR 1/17/2018 H439" label="text"/>
    </vote>
    <action datetime="2018-01-18T19:44:32-05:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2018-01-19">
      <text>Received in the Senate and Read twice and referred to the Committee on Foreign Relations.</text>
    </action>
    <calendar datetime="2018-03-20">
      <text>Committee on Foreign Relations. Ordered to be reported without amendment favorably.</text>
    </calendar>
    <action datetime="2018-03-22">
      <text>Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.</text>
    </action>
    <calendar datetime="2018-03-22" calendar="Senate Legislative" under="General Orders" number="364">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.</text>
    </calendar>
    <vote how="by Unanimous Consent" type="vote2" datetime="2018-12-20" where="s" result="pass" state="PASSED:BILL">
      <text>Passed Senate without amendment by Unanimous Consent.</text>
      <reference ref="CR S8002" label="consideration"/>
    </vote>
    <action datetime="2018-12-21">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <topresident datetime="2018-12-27">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2019-01-03" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="115-411" type="public" datetime="2019-01-03">
      <text>Became Public Law No: 115-411.</text>
    </enacted>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFR" name="Senate Foreign Relations" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="" code="HSFA" name="House Foreign Affairs" activity="Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="International affairs"/>
    <term name="Child health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Foreign aid and international relief"/>
    <term name="HIV/AIDS"/>
    <term name="Health programs administration and funding"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Immunology and vaccination"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Product development and innovation"/>
    <term name="Public-private cooperation"/>
    <term name="U.S. Agency for International Development (USAID)"/>
    <term name="Women's health"/>
    <term name="World health"/>
  </subjects>
  <amendments/>
  <summary date="2019-01-03T21:46:40Z" status="Public Law">Global Health Innovation Act of 2017

 This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

 Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.</summary>
  <committee-reports/>
</bill>
